Cancer Genetics Inc. (CGIX)

0.12
0.00 (0.00)
NASDAQ : Health Services
Prev Close 0.12
Open 0.12
Day Low/High 0.11 / 0.13
52 Wk Low/High 0.10 / 1.30
Volume 1.38M
Avg Volume 1.89M
Exchange NASDAQ
Shares Outstanding 57.82M
Market Cap 6.59M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
Insider Trading Alert - TROX, CGIX And FLTX Traded By Insiders

Insider Trading Alert - TROX, CGIX And FLTX Traded By Insiders

Stocks with insider trader activity include TROX, CGIX and FLTX

The Action Is a Bit Worrisome

Things aren't bad, but the bulls need to go to work soon.

Cancer Genetics, Inc. Receives Approval To Provide Oncology Testing For Patients In California

Cancer Genetics, Inc. Receives Approval To Provide Oncology Testing For Patients In California

Approval Allows CGI to Access Largest National Market for Oncology Testing Services

Insider Trading Alert - AMT, LNC And CGIX Traded By Insiders

Insider Trading Alert - AMT, LNC And CGIX Traded By Insiders

Stocks with insider trader activity include AMT, LNC and CGIX

Insider Trading Alert - BYD, CGIX And AAWW Traded By Insiders

Insider Trading Alert - BYD, CGIX And AAWW Traded By Insiders

Stocks with insider trader activity include BYD, CGIX and AAWW

Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders

Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders

Stocks with insider trader activity include CGIX, NBY and BIOA

Insider Trading Alert - CDW, CGIX And RDNT Traded By Insiders

Insider Trading Alert - CDW, CGIX And RDNT Traded By Insiders

Stocks with insider trader activity include CDW, CGIX and RDNT

Cancer Genetics, Inc. Recognized In Deloitte's 2014 Technology Fast 500(TM) Awards

Cancer Genetics, Inc. Recognized In Deloitte's 2014 Technology Fast 500(TM) Awards

CGI Recognized as One of North America's Fastest Growing Companies Based on Revenue Growth

TheStreet Quant Rating: D- (Sell)